Is 5-MAPB Legal in New Jersey? (2026)

Instrument

statute

Source

https://www.law.cornell.edu/regulations/new-jersey/N-J-A-C-13-45H-10-1

Retrieved

2026-06-19

Fingerprint

b2544b6f71d19e60

**N.J.A.C. 13:45H-10.1(a) (federal incorporation)** — "The Federal controlled dangerous substance Schedules I, II, III, IV and V at 21 CFR 1308.11 through 1308.15, as amended and supplemented, promulgated by the United States Attorney General pursuant to 21 U.S.C. §§ 811 and 812, are incorporated herein by reference."
— N.J.A.C. 13:45H-10.1(a), https://www.law.cornell.edu/regulations/new-jersey/N-J-A-C-13-45H-10-1 (OFFICIAL — Cornell LII reproduction of N.J.A.C.).
**N.J.S.A. 2C:35-2 (controlled substance analog)** — "'Controlled substance analog' means a substance that has a chemical structure substantially similar to that of a controlled dangerous substance and that was specifically designed to produce an effect substantially similar to that of a controlled dangerous substance. The term shall not include a substance manufactured or distributed in conformance with the provisions of an approved new drug application or an exemption for investigational use within the meaning of section 505 of the 'Federal Food, Drug and Cosmetic Act' …" — and: "The term [controlled dangerous substance], wherever it appears in any law or administrative regulation of this State, shall include controlled substance analogs."
— N.J.S.A. 2C:35-2, https://law.justia.com/codes/new-jersey/title-2c/section-2c-35-2/ (MIRROR: Justia).

Instrument

N.J.A.C. 13:45H-10.1 (Schedules of CDS; adopts federal 21 CFR 1308.11-.15 plus state additions), 2017 adoption notice

Source

https://WWW.NJCONSUMERAFFAIRS.GOV/Adoptions/060517-CDS-Adoption.pdf

Retrieved

2026-10-08

Fingerprint

634785e900e19af8

Although New Jersey has adopted, in N.J.A.C. 13:45H-10.1(a), the Federal controlled dangerous substances Schedules I through V codified at 21 CFR 1308.11 through 1308.15, as amended and supplemented, the Director is authorized under N.J.S.A. 24:21-3 to add, delete, or reschedule substances under the New Jersey Controlled Dangerous Substances Act. Full text of the adoption follows: 13:45H-10.1 Schedules of controlled dangerous substances (a)-(d) (No change.) (e) In accordance with (d) above, the following substances shall be designated and controlled as Schedule I controlled dangerous substances: 1.-9. (No change.) 10. Illicit fentanyls. Illicit fentanyls include any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedules I through V, is not a Federal Food and Drug Administration (FDA) approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues (analogs), and salts of isomers, and homologues (analogs) unless specifically excepted whenever the existence of these salts, isomers, homologues (analogs), and salts of isomers and homologues (analogs) is possible within the specific chemical designations: i. Furanyl Fentanyl, with a chemical composition of N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl] -2-furancarboxamide, monohydrochloride or N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-2-carboxamide; ii. 3-Methylfentanyl, with a chemical composition of 3-methyl-N-phenyl-N-[1-(2-phenethyl- 4-piperidyl)-propanamide); iii. 3-Methyl Butyrylfentanyl, with a chemical composition of 3-Methyl, N-phenyl-N-[1-(2- phenylethyl)-4-piperidinyl]-butanamide, monohydrochloride; iv. Valeryl Fentanyl, with a chemical composition of N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl]-pentanamide, monohydrochloride; v. Norfentanyl, with a chemical composition of N-phenyl-N-4-piperidinyl-propanamide; vi. Para-Fluorobutyryl-Fentanyl, with a chemical composition of N-(4-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidinyl]-butanamide, monohydrochloride; and vii. Carfentanyl, with a chemical composition of 2-hydroxypropane-1, 2, 3-tricarboxylic acid; methyl 1-(2-phenylethyl)-4-(N-propanoylanilino) piperidine-4-carboxylateor.

Instrument

Controlled dangerous substance / Controlled substance analog (analogs folded into CDS)

Source

https://law.justia.com/codes/new-jersey/title-2c/section-2c-35-2/

Retrieved

2026-07-20

Fingerprint

b16e837424533ac6

"Controlled dangerous substance" means a drug, substance, or immediate precursor in Schedules I through V, marijuana and hashish as defined in this section, any substance the distribution of which is specifically prohibited in N.J.S.2C:35-3, in section 3 of P.L.1997, c.194 (C.2C:35-5.2), in section 5 of P.L.1997, c.194 (C.2C:35-5.3), in section 2 of P.L.2011, c.120 (C.2C:35-5.3a), or in section 2 of P.L.2013, c.35 (C.2C:35-5.3b), and any drug or substance which, when ingested, is metabolized or otherwise becomes a controlled dangerous substance in the human body. When any statute refers to controlled dangerous substances, or to a specific controlled dangerous substance, it shall also be deemed to refer to any drug or substance which, when ingested, is metabolized or otherwise becomes a controlled dangerous substance or the specific controlled dangerous substance, and to any substance that is an immediate precursor of a controlled dangerous substance or the specific controlled dangerous substance. The term shall not include distilled spirits, wine, malt beverages, as those terms are defined or used in R.S.33:1-1 et seq., tobacco and tobacco products, or cannabis and cannabis as defined in section 3 of P.L.2021, c.16 (C.24:6I-33). The term, wherever it appears in any law or administrative regulation of this State, shall include controlled substance analogs. "Controlled substance analog" means a substance that has a chemical structure substantially similar to that of a controlled dangerous substance and that was specifically designed to produce an effect substantially similar to that of a controlled dangerous substance. The term shall not include a substance manufactured or distributed in conformance with the provisions of an approved new drug application or an exemption for investigational use within the meaning of section 505 of the "Federal Food, Drug and Cosmetic Act," 52 Stat. 1052 (21 U.S.C. s.355).